Neurologic Complications

Shlomit Yust-Katz; Simon Khagi; Mark R. Gilbert

doi:10.1016/B978-0-323-47674-4.00045-1

Neurologic Complications

Shlomit Yust-Katz
, Simon Khagi
, Mark R. Gilbert

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

3 Scopus citations

Abstract

Neurologic complications of cancer-directed therapy are common and require early identification for optimal management. Specific chemotherapies and radiation techniques have well-known neurotoxicity profiles; however, with the advent of targeted therapy and immunotherapy, the spectrum of possible neurologic complications has broadened. The evaluation, grading, and management of the patients presenting with neurologic adverse reactions to cancer-directed therapy is challenging and would benefit from a multidisciplinary approach in order to optimize outcomes.

Original language	English
Title of host publication	Abeloff’s Clinical Oncology
Publisher	Elsevier
Pages	688-706.e7
ISBN (Electronic)	9780323476744
DOIs	https://doi.org/10.1016/B978-0-323-47674-4.00045-1
State	Published - 1 Jan 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cytokine-release syndrome
Immune-related
Immunotherapy
Neuropathy
Neurotoxicity
Targeted therapy

Access to Document

10.1016/B978-0-323-47674-4.00045-1

Cite this

@inbook{cd18297b682443139d05fe6e54593019,

title = "Neurologic Complications",

abstract = "Neurologic complications of cancer-directed therapy are common and require early identification for optimal management. Specific chemotherapies and radiation techniques have well-known neurotoxicity profiles; however, with the advent of targeted therapy and immunotherapy, the spectrum of possible neurologic complications has broadened. The evaluation, grading, and management of the patients presenting with neurologic adverse reactions to cancer-directed therapy is challenging and would benefit from a multidisciplinary approach in order to optimize outcomes.",

keywords = "Cytokine-release syndrome, Immune-related, Immunotherapy, Neuropathy, Neurotoxicity, Targeted therapy",

author = "Shlomit Yust-Katz and Simon Khagi and Gilbert, \{Mark R.\}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2019",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-47674-4.00045-1",

language = "אנגלית",

pages = "688--706.e7",

booktitle = "Abeloff{\textquoteright}s Clinical Oncology",

publisher = "Elsevier",

address = "הולנד",

}

TY - CHAP

T1 - Neurologic Complications

AU - Yust-Katz, Shlomit

AU - Khagi, Simon

AU - Gilbert, Mark R.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Neurologic complications of cancer-directed therapy are common and require early identification for optimal management. Specific chemotherapies and radiation techniques have well-known neurotoxicity profiles; however, with the advent of targeted therapy and immunotherapy, the spectrum of possible neurologic complications has broadened. The evaluation, grading, and management of the patients presenting with neurologic adverse reactions to cancer-directed therapy is challenging and would benefit from a multidisciplinary approach in order to optimize outcomes.

AB - Neurologic complications of cancer-directed therapy are common and require early identification for optimal management. Specific chemotherapies and radiation techniques have well-known neurotoxicity profiles; however, with the advent of targeted therapy and immunotherapy, the spectrum of possible neurologic complications has broadened. The evaluation, grading, and management of the patients presenting with neurologic adverse reactions to cancer-directed therapy is challenging and would benefit from a multidisciplinary approach in order to optimize outcomes.

KW - Cytokine-release syndrome

KW - Immune-related

KW - Immunotherapy

KW - Neuropathy

KW - Neurotoxicity

KW - Targeted therapy

UR - https://www.scopus.com/pages/publications/85123673264

U2 - 10.1016/B978-0-323-47674-4.00045-1

DO - 10.1016/B978-0-323-47674-4.00045-1

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:85123673264

SP - 688-706.e7

BT - Abeloff’s Clinical Oncology

PB - Elsevier

ER -

Neurologic Complications

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this